PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 2, 2026npj Digital Medicine0 citationsOpen Access

Towards a speech-based digital biomarker for cognitive impairment: speech as a proxy for cognitive assessment

View Full Paper
JHJonathan HeitzIEInes EnglerNLNicolas Langer

Key Points

  • The aim is to explore the effectiveness of automated speech analysis as a tool for cognitive assessment in older adults.
  • Analyzed spontaneous speech from 1003 older adults using machine learning regression models.
  • Extracted linguistic and acoustic features to enhance predictive accuracy for cognitive scores.
  • Trained a binary classifier to identify individuals below normative cognitive thresholds.
  • Evaluated the approach with an independent dataset of Alzheimer’s disease patients.
  • Speech analysis significantly increased predictive performance compared to demographic-only models.
  • Achieved a ROC-AUC score of up to 0.81 for identifying cognitive impairment.
  • Demonstrated generalizability in clinical contexts with Alzheimer's disease patients.

Abstract

Abstract With the growing prevalence of cognitive decline in ageing populations, accessible and scalable screening tools are essential for early intervention. This study investigated the potential of automated speech analysis as a proxy for cognitive assessment in 1003 older adults. Employing machine learning regression models, we demonstrated that linguistic and acoustic features extracted from spontaneous speech quadrupled performance compared to models using demographic information alone, when predicting cognitive domain scores. We then trained a binary classifier to identify individuals performing below normative thresholds (ROC-AUC up to 0.81), illustrating possible applications such as large-scale screening for cognitive impairment and improved participant selection for clinical trials. Finally, we evaluated our approach on an independent clinical dataset of Alzheimer’s disease (AD) patients and controls, demonstrating its generalizability. These findings highlight the clinical feasibility of speech analysis as a low-cost, non-intrusive digital biomarker for cognitive monitoring and screening.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Heitz et al. (2026) studied this question.

synapsesocial.com/papers/6980ffd6c1c9540dea8129b8https://doi.org/10.1038/s41746-026-02360-8
Ask AI
Helpful
Bookmark
Share
View Full Paper